Stage IIIB Melanoma
Oncology·MeSH: Melanoma
Prevalence
75.0 / 100K
Incidence
23.0 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Stage IIIB Melanoma?
There are 1 clinical trial targeting Stage IIIB Melanoma tracked by BioSniper.
What is the prevalence of Stage IIIB Melanoma?
The estimated prevalence of Stage IIIB Melanoma is approximately 75.0 per 100,000 population.
Deep-dive into Stage IIIB Melanoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis